Literature DB >> 5844228

Impaired in vitro lymphocyte transformation in Hodgkin's disease.

E M Hersh, J J Oppenheim.   

Abstract

Entities:  

Mesh:

Year:  1965        PMID: 5844228     DOI: 10.1056/NEJM196511042731903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  84 in total

1.  B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.

Authors:  K J Gajl-Peczalska; C D Bloomfield; H Sosin; J H Kersey
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.

Authors:  W J Catalona; J L Tarpley; C Potvin; P B Chretien
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

3.  Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.

Authors:  H Rühl; W Vogt; G Bochert; S Schmidt; R Moelle; H Schaoua
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

4.  Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.

Authors:  P L Amlot; A Unger
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

5.  Lymphocyte transformation in mycosis fungoides.

Authors:  A Langner; W Gliński; M Pawińska; S Obalek
Journal:  Arch Dermatol Forsch       Date:  1975

6.  [Immunologic status in Hodgkin patients: correlation with Epstein-Barr virus titers].

Authors:  V Diehl; K Hegge; J Kalden; U Desselberger; P Krull
Journal:  Blut       Date:  1976-04

7.  Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.

Authors:  F Griesinger; L Bergmann; R Barot-Ciorbaru; P S Mitrou
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Interactions between immunocompetent cells and target cells or antigens.

Authors:  J R David
Journal:  Bull N Y Acad Med       Date:  1967-11

9.  E-rosette inhibiting substance in Hodgkin's disease spleen extracts.

Authors:  M M Bieber; Z Fuks; H S Kaplan
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

10.  Hypoimmunoglobulinaemia: causes, diagnosis and management.

Authors:  L S Salimonu
Journal:  Indian J Pediatr       Date:  1976-05       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.